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Background: As individual naïve CD4 T lymphocytes circulate in the body after emerging from the thymus, they
are likely to have individually varying microenvironmental interactions even in the absence of stimulation via
specific target recognition. It is not clear if these interactions result in alterations in their activation, survival and
effector programming. Naïve CD4 T cells show unimodal distribution for many phenotypic properties, suggesting
that the variation is caused by intrinsic stochasticity, although underlying variation due to subsets created by different
histories of microenvironmental interactions remains possible. To explore this possibility, we began examining the
phenotype and functionality of naïve CD4 T cells differing in a basic unimodally distributed property, the CD4 levels,
as well as the causal origin of these differences.
Results: We examined separated CD4hi and CD4lo subsets of mouse naïve CD4 cells. CD4lo cells were smaller
with higher CD5 levels and lower levels of the dual-specific phosphatase (DUSP)6-suppressing micro-RNA miR181a,
and responded poorly with more Th2-skewed outcomes. Human naïve CD4lo and CD4hi cells showed similar
differences. Naïve CD4lo and CD4hi subsets of thymic single-positive CD4 T cells did not show differences whereas
peripheral naïve CD4lo and CD4hi subsets of T cell receptor (TCR)-transgenic T cells did. Adoptive transfer-mediated
parking of naïve CD4 cells in vivo lowered CD4 levels, increased CD5 and reactive oxygen species (ROS) levels and
induced hyporesponsiveness in them, dependent, at least in part, on availability of major histocompatibility complex
class II (MHCII) molecules. ROS scavenging or DUSP inhibition ameliorated hyporesponsiveness. Naïve CD4 cells from
aged mice showed lower CD4 levels and cell sizes, higher CD5 levels, and hyporesponsiveness and Th2-skewing
reversed by DUSP inhibition.
Conclusions: Our data show that, underlying a unimodally distributed property, the CD4 level, there are subsets
of naïve CD4 cells that vary in the time spent in the periphery receiving MHCII-mediated signals and show resultant
alteration of phenotype and functionality via ROS and DUSP activity. Our findings also suggest the feasibility of
potential pharmacological interventions for improved CD4 T cell responses during vaccination of older people via
either anti-oxidant or DUSP inhibitor small molecules.
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Peripheral residence of naïve CD4 T cells is marked by
many complex microenvironmental interactions. Clonal
T cell receptors (TCRs) expressed on individual T cells
are likely to have variable avidity for the self-peptide
MHC class II (spMHCII) complexes they are positively
selected on in the thymus, and this avidity leads to tuning
of the response of individual T cells [1-3]. Naïve CD4 T
cells survive because they receive tonic signals through
these spMHCII complexes [4]. The levels and availability
of these spMHCII complexes are variable [5], plausibly
leading to variations in the frequencies of tonic signaling
for individual CD4 T cells. Notably, TCR-mediated
signal sensitivity in mouse T cells is also modulated by
miRNA-181a [6], which represses expression of dual-
specific phosphatase-6 (DUSP6), a molecule linked to
human longevity [7] which suppresses phosphorylation
of Erk in human T cells [8]. The levels of CD5, a nega-
tive regulator of TCR signaling [9], show modulations
correlated with the efficiency of TCR-mediated tonic
signaling required for peripheral T cell survival [10-12].
There is also evidence that persistent tonic signaling
itself may lead to hyporesponsiveness and reduction in
co-receptor levels in naive CD8 T cells [13].
Further, naïve T cells can proliferate in the periphery
in a cognate ligand-independent fashion if they are in
lymphocyte-depleted environments such as during early
fetal-neonatal development in the neonatal mouse or in
the aged animal with reduced thymic output [14-17],
although the precise functional consequences of such
homeostatic proliferation are not yet clear [17,18]. Cyto-
kines such as IL-2, −7, −15 and their receptors have
been implicated in peripheral T cell homeostasis and
survival [18-20], and common receptor gamma-chain-
deficient naive CD4 cells in the periphery are smaller
in size [19], consistent with the possibility that cellular
metabolism may be a major variable in determining per-
ipheral survival and functionality of naïve T cells [21-23].
Finally, stochasticity in levels of gene expression and
responsiveness is expected to mark any apparently
homogenous population of cells including T cells [24-29],
although it is difficult to distinguish between subset-
dependent variations and true statistical noise.
The thymus continuously exports naïve mature T cells
to the periphery with declining output due to age-
associated involution. Many of these naïve T cells in the
periphery remain naïve until their eventual loss from the
peripheral pool [30]. Thus, the post-thymic, peripheral
residence times of naive T cells at any given point in
time would be variable. As thymic output decreases with
age, naïve T cells in the periphery also appear to be
longer-lived [16-18,31]. Thus, it is likely that the naïve T
cells from aged animals will show a longer average per-
ipheral residence time than those from young individuals[32,33], and this may be connected to the functional
CD4 T cell defects seen in aged animals [16,34]. While
there are some markers to identify recent thymic emi-
grants [35,36], there are currently no phenotypic modal-
ities to measure peripheral residence time in individual
naïve T cells in heterogeneous populations.
On this background, we began looking for variable
functional behavior in mouse (and human) peripheral
naïve CD4 (NCD4) T cells differing in properties that
were apparently unimodally distributed, with the initial
expectation that these differences would be stochastic in
nature. CD4 was chosen since it shows low variance in
its distribution and is uniformly present without major
alterations through the entire lifespan of CD4 T cells.
We find that the top and bottom decile of CD4 levels in
NCD4 T cells define cells that are both phenotypically
and functionally different, with NCD4lo cells having
smaller sizes, higher CD5 levels, poor responses, lower
levels of the DUSP6-suppressing micro-RNA181a, and
greater susceptibility to death and to Th2-skewing. How-
ever, we find that these differences are not stochastic;
they are not found in NCD4lo and NCD4hi T cells in
the thymus, but they persist even when the TCR reper-
toire of the CD4 T cell population is homogenized as in
NCD4 T cells from TCR-transgenic mice, and they can
be induced by exposure in vivo to MHCII-mediated
tonic signals during a few days of peripheral residence,
indicating that unimodal distribution of a variable does
not necessarily mean that the variability is stochastic.
DUSP and reactive oxygen species (ROS) appear to me-
diate the MHCII-induced hyporesponsiveness of NCD4
T cells, since ROS scavenging or DUSP inhibition ameli-
orate it. Finally, consistent with the greater average time
of peripheral residence of NCD4 T cells in aged animals
[16], we find that the properties found in NCD4lo T
cells from young mice are also found in the NCD4 T
cells of aged mice, making ROS and DUSP potential
targets for intervention for successful vaccination in the
older population.
Results
Despite unimodal distribution, CD4 levels on naïve CD4 T
cells are correlated with responsiveness
NCD4 cells show unimodal distribution of CD4 levels. To
examine whether this apparently homogenous population
has any functional consequences, we sorted mouse splenic
NCD4 cells (CD4 +CD25-CD44-CD62L+) into the bright-
est (NCD4hi) and dullest (NCD4lo) deciles of CD4 levels
(Figure 1A). There was no overlap in the CD4 levels of
these sorted populations, which typically differed by
approximately two-fold (Figure 1A). We next charac-
terized these sorted NCD4hi and NCD4lo cells in func-
tional terms. Purified cells were activated with plate-coated
anti-CD3 + anti-CD28 monoclonal antibodies (mAbs) for
Figure 1 Despite unimodal distribution, CD4 levels on naïve CD4 T cells are correlated with responsiveness. A. Gating strategy used to
sort NCD4lo and NCD4hi cells from six- to eight-week-old mice. Right panel shows sort profile for NCD4hi and NCD4lo cells. B. CD69 expression
on anti-CD3 + anti-CD28 (3 μg/ml each) stimulated NCD4lo and NCD4hi cells 16 hours post-activation. Numbers indicate representative proportions of
CD69+ cells in NCD4hi (black) and NCD4lo (grey) cells. C. Proportions of CD69+ cells in a dose–response curve with 3 μg/ml of anti-CD28 and titrating
anti-CD3 concentrations as shown. (Mean ± SE, n = 4; n.s.: not significant). D. Amount of IL-2 detected 48 hours post-stimulation with anti-CD3 +
anti-CD28 in culture supernatants. (Mean ± SE, n = 3; Background values shown as a line). E. 3H-Thymidine incorporation assay to measure proliferation
60 hours post stimulation with anti-CD3 + anti-CD28. (Mean ± SE of triplicate cultures, 1 of >7 experiments). F. 3H-Thymidine incorporation assay on
sorted NCD4hi and NCD4lo cells cultured in vitro with IL-2 for 24 hours prior to stimulation with anti-CD3 + anti-CD28 for 60 hours. (Mean ± SE
of triplicate cultures, one of three experiments). G. Proportion of trypan blue-positive cells 16 hours post-activation (Mean ± SE, n = 6, data
representative of four experiments). H. Cytokine levels in supernatants of in vitro primed and recalled NCD4hi and NCD4lo cells. I. IFNγ/IL-4 ratios and
mean ± SE calculated based on absorbance values. SE, standard error.
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of CD69 as an early activation marker was estimated.
Smaller proportions of NCD4lo cells than of NCD4hi
cells expressed CD69 at multiple anti-CD3 concen-
trations (Figures 1B and C). Further, NCD4lo cells pro-
duced less IL-2 at 48 hours (Figure 1D) and incorporated
less (3H)-thymidine at 60 hours post-activation (Figure 1E).
Poor proliferation of activated NCD4lo cells was also
confirmed in a carboxyfluorescein succinimidyl ester
(CFSE) dilution assay (see Additional file 1: Figure S1A-B).
We examined the possibility that anti-CD4 antibodybound during sorting signals differentially to the NCD4hi
and NCD4lo cells, by resting the sorted cells for 24 hours
in IL-2 before stimulating them with anti-CD3 + anti-
CD28 for 48 hours. The difference in their proliferative
responses persisted, indicating that it was not related to
any anti-CD4-mediated signaling artifact (Figure 1F).
Since IL-2 induction was different between NCD4lo and
NCD4hi cells, we tested if exogenous IL-2 supplementa-
tion could abolish the difference. When exogenous IL-2
(10 U/ml) was added during activation, NCD4lo cells
showed some improvement in proliferative responses at
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responses reach levels achieved by NCD4hi cells (see
Additional file 1: Figure S1C), suggesting that, while
differential IL-2 production may contribute to the dif-
ference, it was unlikely to represent the sole explan-
ation. There was more prominent activation-induced
cell death in NCD4lo cells at 24 hours post-activation,
as scored by trypan blue staining, than in NCD4hi cells
(Figure 1G).
We also tested the ability of sorted NCD4hi and
NCD4lo cells to differentiate in vitro in response to non-
polarizing activating conditions (described in detail in
Methods). Supernatants from cultures of NCD4hi and
NCD4lo cells primed in vitro with anti-CD3 + anti-CD28
for three days and then restimulated with titrating doses
of anti-CD3 were analyzed for IFNγ and IL-4. Effector
cells generated from NCD4lo cells produced more IL-4 as
compared to those from NCD4hi cells (Figure 1H). TheFigure 2 NCD4lo cells show higher CD5 levels but no difference in pr
gated NCD4lo and NCD4hi cells. B. Comparison of CD5 levels as log (left) a
values for NCD4hi and NCD4lo cells (Mean ± SE, one of three experiments)
E. Forward scatter values on NCD4hi and NCD4lo cells (Mean ± SE, one of five
plots between NCD4hi and NCD4lo cells. G. TCRβ MFI values for NCD4hi and N
profile of Fluo-3/Fura-Red ratio in NCD4hi and NCD4lo cells at rest and post-ac
in Fluo-3/Fura-Red ratio with anti-CD3 (10 μg/ml) + anti-CD28 (3 μg/ml) treatm
MFI in NCD4hi and NCD4lo cells activated with anti-CD3 + anti-CD28, mean ± S
error; TCR, T cell receptor.relative Th1/Th2 dominance, indicated by the IFNγ/IL-4
ratio, was significantly lower in differentiated NCD4lo cells
(Figure 1I).
NCD4lo cells show complex phenotypic modifications,
but no differences in proximal signaling events
CD5 is a negative regulator of TCR signaling [10] and
CD5 expression has been inversely correlated with T cell
responsiveness [37]. We, therefore, tested the possibility
that lower CD4 levels might correlate with higher CD5
expression. NCD4hi and NCD4lo cells from young B6
mice (Figure 2A) were tested for the levels of CD5.
When gated NCD4hi and NCD4lo cells were analyzed
for CD5 expression, it was apparent that NCD4lo cells
had higher CD5 levels (Figure 2B, log plot on left, linear
on right) in multiple mice analyzed (Figure 2C). This
was despite the finding that NCD4hi cells were some-
what larger than NCD4lo cells (Figures 2D and E). Weoximal signaling. A. Ex vivo analysis of stained splenic cells to show
nd linear (right) plots between NCD4hi and NCD4lo cells. C. CD5 MFI
. D. Comparison of forward scatter between NCD4hi and NCD4lo cells.
experiments). F. Comparison of TCRβ levels as log (left) and linear (right)
CD4lo cells (Mean ± SE, one of three experiments). H. Representative
tivation. I. Pooled data from independent mouse spleens showing increase
ent J. Pooled data for fold increase over background in pZap-70 staining
E. MFI, mean fluorescence intensity; NCD4, naïve CD4 T cells; SE, standard
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markers in these populations. NCD4lo cells showed lower
TCRβ (Figure 2F, log and linear plots; and 2G) levels that
NCD4hi cells, although both NCD4lo and NCD4hi cells
were confirmed to be conventional CD4 T cells expressing
TCRα/β. NCD4lo cells also expressed somewhat lower
levels of MHC class I and CD2, but higher levels of CD54
(see Additional file 2: Figure S2A and S2B) in multiple
mice examined. Another feature tested based on differ-
ences in cell size between NCD4lo and NCD4hi cells was
mitochondrial mass and potential using indicator dyes,
Mitotracker Green (MG) and Mitotracker Red (MR)
[38,39]. However, NCD4lo cells did not show any striking
differences from NCD4hi cells in mitochondrial content
or potential (see Additional file 2: Figure S2C to S2E).
These data indicated that the phenotypic differences
between NCD4lo and NCD4hi cells were likely to be
complexly regulated.
Since far-downstream proliferative outcomes of TCR
activation differed between NCD4lo and NCD4hi cells,
we next examined proximal signaling events after ligation
with anti-CD3 + anti-CD28. Activation-induced calcium
flux (as measured by an increase in Fluo-3/Fura-Red
ratios) was indistinguishable between NCD4hi and NCD4lo
cells (Figure 2H, 2I and Additional file 2: Figure S2F). Simi-
larly, total Zap-70 levels were comparable between NCD4hi
and NCD4lo cells (see Additional file 2: Figure S2G, left
panel), and the induction of Zap-70 phosphorylation
upon activation for five minutes did not differ between
NCD4lo and NCD4hi cells (Figure 2J and Additional file 2:
Figure S2G, middle and right panels as log and linear
plots). Similarly, total Lck levels were comparable in
NCD4lo and NCD4hi cells, and the extent of p-Lck induc-
tion at five minutes post-activation was similar between
them (see Additional file 2: Figure S2H). Together, these
data suggest that proximal signaling is not different be-
tween NCD4hi and NCD4lo cells, and that the differences
between them may lie further downstream.
Hypo-responsiveness associated with NCD4lo cells develops
exclusively in the periphery and is also seen in monoclonal
T cells
In order to see if these properties of NCD4hi and NCD4lo
cells is an intrinsic characteristic in developing NCD4
populations, we tested thymic mature single-positive (SP)
CD8-CD4 + CD24-Qa2+ NCD4 cells. When these cells
were gated to identify CD4lo and CD4hi cells (Figure 3A,
log and linear plots), it was apparent that they show no
differences in either cell size (Figure 3A, right panel) or
CD5 levels (Figure 3B, log and linear plots). When these
CD4lo and CD4hi CD4SP thymocytes were sorted and
activated with plate-coated anti-CD3 + anti-CD28 they
responded comparably (Figure 3C) unlike NCD4lo and
NCD4hi cells from the periphery (Figure 1). These dataindicate that the functional and phenotypic differences
observed between peripheral NCD4lo and NCD4hi cells
are not thymic in origin.
In order to examine if the hyporesponsiveness of NCD4lo
cells could be plausibly ascribed to differences in the
normal polyclonal TCR repertoire [40], we sorted splenic
NCD4hi and NCD4lo cells from mice transgenic for
an MHCII-restricted TCR (OT-II) and stimulated these
sorted cells with titrating concentrations of the cognate
ovalbumin peptide (OVA-II) presented by bone-marrow
derived dendritic cells (BMDCs) as antigen-presenting
cells (APCs). NCD4lo OT-II cells responded poorly to
cognate peptide and produced less IL-2 than NCD4hi
OT-II cells did (Figure 3D and E), showing that even in
naïve T cells with a single TCR, CD4 levels were corre-
lated with responsiveness.
Human NCD4lo and NCD4hi cells show properties similar
to those from mice
We tested if the distinctions observed between NCD4lo
and NCD4hi mouse cells were also found in human
CD4 cells. For this, we examined NCD4 cells (CD4+
CD45RA + CD25-) from human peripheral blood mono-
nuclear cells (PBMCs) from healthy donors. When gated
NCD4hi and NCD4lo populations (Figure 4A, left panel)
were examined, NCD4lo cells were smaller in size in
multiple donors (Figure 4A, right panel, Figure 4B), con-
sistent with the mouse data. Sorted human NCD4hi and
NCD4lo cells showed about two-fold difference in CD4
mean fluorescence intensity (MFI) values (Figure 4A,
middle panel) similar to mouse cells. Upon activation
with plate-coated anti-CD3 + anti-CD28 mAbs, NCD4hi
cells proliferated much more than NCD4lo cells did
(Figure 4C). Mitochondrial mass and membrane poten-
tial were also evaluated in these cells using MG and MR
(Figure 4D and F respectively; left log plots, right linear
plots) as for mouse cells. Similar to mouse NCD4lo cells,
human NCD4lo cells, too, showed no striking differ-
ences from NCD4hi cells in mitochondrial mass and
potential (Figure 4E to G).
Consequences of peripheral residence on NCD4 T cells
The data so far suggest that the association between
CD4 levels and functional phenotype was a peripherally
induced characteristic. In order to probe this further, we
began by sorting splenic NCD4lo and NCD4hi cells. We
labelled these cells with green and violet dyes for identi-
fication, mixed them in 1:1 proportion and transferred
them intravenously (i.v.) to wild type (WT) recipients.
On day 4 post-transfer, donor NCD4 cells were identi-
fied in recipient spleens and analyzed for their CD4
levels. Comparison of CD4 levels on NCD4hi and
NCD4lo cells before (d0) and after transfer (d4), done in
parallel, showed that adoptively transferred NCD4lo cells
Figure 3 Hypo-responsiveness associated with NCD4lo cells develops exclusively in periphery and is also seen in monoclonal T cells.
A. Ex vivo analysis of stained thymic cells to show single positive mature CD4lo and CD4hi cells (log and linear plots), and corresponding forward
scatter (right) (one of three experiments). B. Levels of CD5 in log (left) and linear (right) scale from the same experiment as in A. C. 3H-Thymidine
incorporation assay to measure proliferation of sorted thymic single positive mature CD4lo and CD4hi cells 60 hours post-activation with anti-CD3
(1 μg/ml) and anti-CD28 (3 μg/ml) (Mean ± SE of triplicate cultures, one of three experiments). D. 3H-Thymidine incorporation at 60 hours of sorted
NCD4lo and NCD4hi cells from TCR transgenic OT-II mice to titrating concentrations of OVA-II peptide with irradiated B6 DCs as APCs (mean ±
SE of triplicate cultures, one of four experiments). E. Amount of IL-2 estimated from supernatants 48 hours post stimulation. Data from one of
four experiments. APCs, antigen-presenting cells; DCs, dendritic cells; NCD4, naïve CD4 T cells; SE, standard error; TCR, T cell receptor.
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were lower than transferred NCD4hi cells (Figure 5A,
left and middle panels log plots, right panel linear plot).
CD4 levels on NCD4hi cells declined from d0 levels to
day 4 after transfer, indicating that naïve CD4 T cells
lose CD4 levels over time in the periphery. However,
despite this decline, NCD4hi cells continued to have
higher CD4 levels than NCD4lo cells up to day 7 after
transfer (Figure 5B). Notably, there was no appreciable
difference in the ability of transferred cells to survive
in vivo, at least for a period of one week (Figure 5C).
These data suggest that CD4 levels do not change
randomly in vivo but are likely to be reduced over time,
perhaps with longer residence.We also used the lymphoreplete environment of WT
congenic mice to analyze the consequences of prolonged
peripheral residence on NCD4 T cell function. B6.SJL
mice were given 5 × 106 OT-II cells and the proliferative
responses of these donor cells in vitro were analyzed
one to eight weeks later. OT-II cells parked for five
weeks in vivo responded poorly in terms of proliferation
and IL-2 production than those parked for one week
(Figure 5D and E). When CD4 levels on these parked
OT-II cells were analyzed, OT-II cells parked for one
week showed higher CD4 levels compared to cells
parked for eight weeks (Figure 5F, log and linear plot).
When OT-II cells parked for less than two weeks were
compared with those parked for more than four weeks
Figure 4 NCD4lo and NCD4hi cells from human PBMCs show properties similar to mouse cells. A. A representative gating strategy for
NCD4lo and NCD4hi cells (left), histogram overlay of sorted NCD4lo and NCD4hi cells (middle) and analysis of the same cells for size (right). B.
Forward scatter for NCD4hi and NCD4lo cells from individual donors (Mean ± SE). C. 3H-Thymidine incorporation in response to titrating doses of
anti-CD3 and 3 μg/ml of anti-CD28 60 hours post-activation (Mean + SE of triplicate cultures; one of four independent donors). D. Histogram
overlays for MG staining in log (left) and linear (right) scale in NCD4lo and NCD4hi. E. MFI for MG on NCD4hi and NCD4lo cells from six individual
donors (mean ± SE). F. Histogram overlays for MR staining in log (left) and linear (right) scale in NCD4lo and NCD4hi. G. MFI for MR on NCD4hi and
NCD4lo cells from six individual donors (mean ± SE). MFI, mean fluorescence intensity; MG, Mitotracker Green; MR, Mitotracker Red; NCD4, naïve CD4 T
cells; PBMC, peripheral blood mononuclear cells; SE, standard error.
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differences were found in their relative CD4 levels
(Figure 5G). DO11.10 cells parked in Balb.c mice for
six months showed lower CD4 levels compared to
those parked for two weeks (see Additional file 3:
Figure S3A and S3B).Consequences of prolonged tonic signaling and absence
of tonic signaling in naïve T cells
The data so far suggested the hypothesis that CD4 levels
and the responsiveness of NCD4 cells were reduced
with increasing duration of peripheral residence. During
peripheral residence, MHCII-mediated tonic signals are
Figure 5 Consequences of peripheral residence in NCD4 T cells. A. CD4 levels on sorted, and differentially labeled NCD4lo (left and right)
and NCD4hi (middle and right) cells prior to (day 0) and four days after transfer. Left and middle panel – log plots, right panel – an overlay in
linear scale (one of three experiments). B. CD4 MFI values for NCD4lo and NCD4hi cells seven days post-transfer. Each circle represents an individual
recipient mouse and the horizontal line indicates mean ± SE. C. Number of transferred NCD4hi and NCD4lo cells recovered from individual recipient
mouse spleens seven days post-transfer shown as mean ± SE (one of two experiments). D. 3H-Thymidine incorporation in OT-II cells parked in WT mice
for one or five weeks in response to titrating concentrations of OVA-II peptide. Data normalized for 200 OT-II cells (Mean ± SE of triplicate cultures; 1
of >7 experiments). Horizontal line indicates background cpm. E. Levels of IL-2 in culture supernatants from a representative experiment as in
panel D. Horizontal line indicates background IL-2 levels (one of five experiments). F. Histogram overlays showing CD4 levels as log and linear
plots of one-week-parked or eight-week-parked OT-II cells. G. CD4 MFI levels from long-parked (>4 week) and short-parked (<2 week) OT-II cells
(Mean ± SE, one of six experiments). MFI, mean fluorescence intensity; NCD4, naïve CD4 T cells; SE, standard error; WT, wild type.
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levels and the loss of responsiveness were related to
MHCII-mediated tonic signaling, we ‘parked’ purified
NCD4 OT-II cells by adoptive transfer into either WT
or MHCII-null recipient mice. When recipients were
euthanized on day 3 post-transfer, the numbers of OT-II
cells recovered per spleen from WT and MHCII-null re-
cipients were comparable (Figure 6A) suggesting that
there is unlikely to be a major difference in cell survival
or homeostatic proliferation in the two groups at this time
post-transfer. However, NCD4 OT-II cells recovered from
WT recipients had lower CD4 levels (Figure 6B, log and
linear plot and 6C) and higher CD5 levels (Figure 6D
log and linear plots, and 6E) than cells recovered fromFigure 6 Consequences of prolonged tonic signaling and absence of
NCD4 OT-II cells recovered from spleens three days after transfer into WT and
of CD4 levels (plotted on log on left and linear scale on right) of donor NCD4
paired samples showing CD4 MFI and mean ± SE (one of three experiments).
right) of donor NCD4 OT-II cells after three days in WT and MHCII-null mice. E
of three experiments). F. Proliferation assay of donor NCD4 OT-II cells from
to OVA-II peptide in the presence of irradiated DCs from WT mice. Data were
cultures; data representative of two experiments; three recipient mice per gro
left and linear scale on right) for donor OT-II cells from WT or MHCII-null s
showing DCFDA MFI values (Mean ± SE, one of three experiments) in WT
DCFDA, 2-7-dichlorofluorescin diacetate; MFI, mean fluorescence intensityMHCII-null recipients. When these cells were stimulated
with the cognate OVA-II peptide, OT-II cells parked in
MHCII-null recipients responded better than the corre-
sponding cells parked in WT recipients (Figure 6F).
Since accumulation of ROS is a common hallmark of
senescent cells [21-23], we examined the possibility that
longer parking of OT-II NCD4 cells in WT versus MHCII-
null recipients may also lead to differences in ROS levels in
them. When NCD4 OT-II cells were parked for ten days in
WT or MHCII-null recipients, and their levels of staining
intensity for the ROS indicator dye 2-7-dichlorofluorescin
diacetate (DCFDA) examined, cells parked in WT mice
showed higher ROS levels than cells parked in MHCII-null
recipients (Figure 6G log and linear plots, and 6H).tonic signaling in naïve T cells. A. Numbers of adoptively transferred
MHCII-null mice (one of three independent experiments). B. Comparison
OT-II cells after three days in WT and MHCII-null mice. C. Pooled data, of
D. Comparison of CD5 levels (plotted on log on left and linear scale on
. Pooled data, of paired samples showing CD5 MFI and mean ± SE (one
WT or MHCII-null recipient mice four days post-transfer in response
normalized for 1,000 donor NCD4 OT-II cells (Mean ± SE of triplicate
up per experiment). G. Representative DCFDA staining (plotted on log on
pleen cells seven days post-transfer. H. Pooled data, of paired samples
or MHCII-null recipients seven days after transfer. DCs, dendritic cells;
; NCD4, naïve CD4 T cells; SE, standard error; WT, wild type.
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and accumulation of ROS in NCD4 cells
We next examined if ROS levels differed in parked cells in
normal lymphoreplete mice depending on the duration
of parking. OT-II cells parked for eight weeks in WT
congenic lymphoreplete mice showed higher intensities
of DCFDA staining as compared to cells parked for one
week (Figure 7A, log and linear plots). In multiple ex-
periments when OT-II cells parked for less than two
weeks were compared with those parked for more than
four weeks, significant differences were found in their
relative DCFDA staining intensities (Figure 7B).
We next tested if ROS scavenging could ameliorate the
relative hyporesponsiveness induced in OT-II cells by pro-
longed parking. OT-II cells were adoptively transferredFigure 7 Prolonged residence in vivo leads to loss of functionality
and accumulation of ROS in NCD4 cells. A. Histogram overlays
(plotted on log on left and linear scale on right) for DCFDA from OT-II
cells parked for one or eight weeks in WT mice. B. DCFDA MFI values
from long-parked (>4 weeks) and short-parked (<2 weeks) OT-II cells
(mean ± SE, one of three experiments). C. 3H-Thymidine incorporation
in response to titrating concentrations of OVA-II peptide in OT-II cells
parked for one or six weeks in WT mice (with or without Euk-134
treatment). Data normalized to 200 OT-II cells (Mean ± SE of triplicate
cultures; one of three experiments). Horizontal line indicates background
cpm. DCFDA, 2-7-dichlorofluorescin diacetate; MFI, mean fluorescence
intensity; NCD4, naïve CD4 T cells; ROS, reactive oxygen species; SE,
standard error; WT, wild type.into WT recipients that were given alternate-day treat-
ment with either vehicle alone or a superoxide dismutase
(SOD)/catalase mimic, Euk-134 [41], for five weeks follow-
ing adoptive transfer. WT recipients given OT-II cells one
week previously were also used as a control group. OT-II
cells from Euk-134-treated recipients showed a better
proliferative response at the end of six weeks of parking
compared to cells from vehicle- treated recipients,
although their responses still remained poorer than
those of OT-II cells parked for only one week (Figure 7C).
Since ROS level differences had become evident by
10 days or so, we tested if a shorter period of Euk-134
treatment was sufficient to improve reactivity of parked
OT-II cells. However, 15-day Euk-134 treatment did not
result in any improvement of reactivity (see Additional
file 3: Figure S3C). These data suggest that the ROS-
mediated contribution to hyporeactivity requires fairly
prolonged ROS exposure, and, thus, ROS is clearly not
the major factor imposing hyporeactivity on NCD4 cells
upon prolonged peripheral residence.
The Erk-DUSP6-miR-181a axis contributes to
hyporesponsiveness of NCD4 T cells during peripheral
residence
Phosphorylation of mitogen-activated protein (MAP)
family tyrosine kinase Erk has been shown to be poor in
many aging cells, including T cells [6,8,42,43] suggesting
that T cell age may also be correlated with Erk phos-
phorylation. We examined baseline p-Erk levels ex vivo
in NCD4hi and NCD4lo cells. NCD4lo cells show
significantly lower levels compared to NCD4hi cells
(Figure 8A log and linear plot, and 8B). The defective
phosphorylation of Erk in human T cells is regulated
by the activity of DUSP6, which in turn is controlled
by miR-181a [8]. NCD4 cells from older people are
reported to express lower levels of miR-181a (relative
to a control miRNA, miR-142) than NCD4 cells from
young people [8]. We therefore estimated the levels of
miR-181a and miR-142 transcripts in mouse T cells
using real-time RT-PCR assays. Levels of miR-181a
transcripts (normalized to miR-142 transcript levels)
were lower in NCD4lo cells compared to NCD4hi cells
(Figure 8C), further suggesting that because of longer
peripheral residence NCD4lo cells show a pattern similar
to that reported in NCD4 T cells from older individuals
[8]. Consistent with the role of miRNA-181a in suppress-
ing DUSP6 expression [8], when NCD4lo and NCD4hi
cells were treated with a pharmacological inhibitor of
DUSP, (E)-2-benzylidene-3-(cyclohexylamino)-2,3-dihy-
dro-1H-inden-1-one (BCI) prior to activation, NCD4lo
cells responded better following treatment with BCI
(Figure 8D), while NCD4hi cells showed no effect of BCI.
Further, analysis of cytokines secreted by NCD4lo and
NCD4hi cells treated with BCI and differentiated in vitro
Figure 8 The Erk-DUSP6-miR181a axis contributes to hypore-
sponsiveness of NCD4lo T cells. A. Histogram overlays of baseline
ex vivo p-Erk (plotted on log on left and linear scale on right) in
NCD4lo and NCD4hi cells. B. Pooled data of paired samples showing
baseline p-Erk MFI values (Mean ± SE) in NCD4lo and NCD4hi cells.
C. ΔΔCt values of Real time RT-PCR for miR-181a normalized to miR-142
on NCD4hi and NCD4lo cells (Mean ± SE from four sets of independently
sorted cells). D. 3H-Thymidine incorporation of NCD4lo and NCD4hi
cells treated or not with BCI prior to activation (Mean ± SE of triplicate
cultures). Data representative of five mice, one of three experiments.
E. Relative IFNγ/IL-4 and IFNγ/IL-13 ratios for BCI treated or untreated
NCD4lo cells during recall response. Data from three independent
experiments shown normalized to respective ratios for NCD4hi cells as
100%, shown as a dotted line. BCI, (E)-2-benzylidene-3-(cyclohexylamino)-
2,3-dihydro-1H-inden-1-one; DUSP6, dual-specific phosphatase 6; MFI,
mean fluorescence intensity; NCD4, naïve CD4 T cells; SE, standard error.
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was partially reversed by BCI treatment (Figure 8E).
Phenotypic and functional features of NCD4 cells from
young mice with longer peripheral residence are similar
to NCD4 cells from aged mice
Average peripheral residence time of naive T cells in
aged mice and older people is reported to be longer
than their younger counterparts due to decreasing
thymic output with age [16,17]. Since our data above
suggest that NCD4lo cells from young mice are likely tobe those with longer peripheral residence, we compared
NCD4 cells from young (YNCD4) and aged (ANCD4)
mice for functional and phenotypic features. We have
already shown that ANCD4 cells respond poorly and
die more easily post-activation [34]. We observed that
ANCD4 cells had modestly but consistently lower CD4
levels than YNCD4 cells (Figure 9A log and linear plot,
and 9C). ANCD4 cells were also consistently smaller
than YNCD4 cells (Figure 9B and D). We also looked at
the ability of sorted ANCD4 and YNCD4 cells to differ-
entiate in vitro in response to non-polarizing activating
conditions. Supernatants from cultures of ANCD4 and
YNCD4 cells primed in vitro with anti-CD3 + anti-CD28
for three days and then restimulated with titrating doses
of anti-CD3 were analyzed for IFNγ, IL-4 and IL-13.
ANCD4 cells thus differentiated to effector cells pro-
duced more IL-4 and IL-13 compared to YNCD4 cells
(Figure 9E). The relative Th1 dominance, indicated by
the IFNγ/IL-13 ratio, was significantly lower in differen-
tiated ANCD4 cells (Figure 9F). We also examined total
and p-Erk levels. While total Erk levels (Figure 9G log and
linear scale, bottom plot) were not different between
ANCD4 and YNCD4 cells ex vivo, p-Erk levels in the
resting state were lower in ANCD4 cells (Figure 9G log
and linear scale, top plot). Differences in the pErk levels
were significant (Figure 9H). In multiple independent
experiments, relative levels of miR-181a were lower in
ANCD4 cells compared to YNCD4 cells (Figure 9I)
extending observations reported on human cells [8].
Consistent with the role of miRNA-181a in suppressing
DUSP6 expression [8], ANCD4 cells responded better
when treated with a pharmacological inhibitor of DUSP,
BCI, prior to activation (Figure 9J). It is noteworthy that
there was no apparent effect of BCI on YNCD4 cells,
despite the fact that some of the YNCD4 cells would be
expected to be CD4lo and would, therefore, have shown
an effect of BCI. It is likely that the contribution of
NCD4lo cells in the bulk YNCD4 cells may not be
statistically apparent. Further, analysis of cytokines
secreted by ANCD4 and YNCD4 cells treated with BCI
and differentiated in vitro showed that the relative Th2
tendency of ANCD4 cells was partially reversed by BCI
treatment (Figure 9K).
Discussion
Functional variations in apparently homogeneous cell
populations have been recognized based on gene induc-
tion [27] as well as expression of protein levels [28,29].
The origins of such variation can be either stochastic
and/or can lie in the different experiential histories of
individual cells. Our data here show that differences
in CD4 levels in an NCD4 cell population showing
unimodal distribution are associated with differences
in cell size, CD5 expression levels, and ability to
Figure 9 NCD4lo cells resemble naïve CD4 T cells from aged mice in their phenotypic and functional attributes. A. CD4 levels on ANCD4
and YNCD4 cells (plotted on log on left and linear scale on right) stained as a mixture in a single well. B. Representative forward scatter histograms for
ANCD4 and YNCD4 cells. C. Comparison of CD4 MFI values of ANCD4 and YNCD4 cells (Mean ± SE; data representative of three experiments). D. Data
for forward scatter from individual mice (Mean ± SE; data representative of three experiments). E. Representative data showing levels of cytokines in
supernatants of in vitro primed and recalled YNCD4 and ANCD4 cells. F. IFNγ/IL-13 ratios and mean ± SE calculated based on absorbance values. G.
Histogram overlays of baseline ex vivo p-Erk (top) and total Erk (bottom) in ANCD4 and YNCD4 cells (plotted on log on left and linear scale on right).
H. Pooled data, of paired samples showing baseline p-Erk MFI values (Mean ± SE) in ANCD4 and YNCD4 cells. I. ΔΔCt values of Real time RT-PCR for
miR-181a normalized to miR-142 on ANCD4 and YNCD4 cells (Mean ± SE from five sets of independently sorted cells). J. 3H-Thymidine incorporation of
ANCD4 and YNCD4 cells treated or not with BCI prior to activation (Mean ± SE of triplicate cultures). Data representative of six mice, one of
three experiments. K. IFNγ/IL-13 and IFNγ/IL-4 ratio for YNCD4, BCI treated ANCD4 or BCI untreated ANCD4 cells during recall response. Data
representing one of four independent experiments. ANCD4, naïve CD4 T cells from aged mice; BCI, (E)-2-benzylidene-3-(cyclohexylamino)-2,
3-dihydro-1H-inden-1-one; MFI, mean fluorescence intensity; SE, standard error; YNCD4, naïve CD4 T cells from young mice.
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also indicate that these differences are not purely sto-
chastic but are influenced by microenvironmental
MHCII-mediated signals received by peripheral NCD4
cells. Finally, we also show that the resultant variations
in responsiveness are influenced by ROS accumulation
and DUSP function, providing entry points for envisaging
immunotherapeutic interventions in older people.Despite the unimodal distribution, the gated top and
bottom CD4 level deciles of NCD4 cells show distinct
differences in both mice and humans. The NCD4lo cells
respond poorly to activation, and their response matures
in a more Th2-skewed direction. CD4 is a co-receptor
and signals mediated by CD4-MHCII interaction can
contribute to peptide-MHCII-mediated signaling for ac-
tivation in naive T cells [44]. However, the anti-CD3 +
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to bypass any direct contribution of CD4. The CD4
molecules on responding NCD4 cells are antibody-
engaged in our purification protocols, and there is some
evidence for TCR-independent signaling capabilities of
CD4 molecules [44]. However, our data on proximal
signaling events such as Zap-70 or Lck phosphorylation
and calcium flux induction show no evidence for their
modification during activation of NCD4lo and NCD4hi
cells, indicating that differential CD4-mediated signals
induced by the anti-CD4 antibody are not responsible
for the differences we observe, and that the differences
in CD4 levels per se are unlikely to be directly involved
in the hyporesponsiveness of NCD4lo cells. It is more
likely that CD4 levels are simply correlates of global
alterations in these populations. Notably, NCD4lo and
NCD4hi cells differ in their IL-2 production, a charac-
teristic property of ‘anergic’ CD4 T cells [45]. However,
exogenous IL-2 supplementation only partially corrects
the proliferative deficit in NCD4lo cells, and NCD4lo
cells remain quite capable of generating CD4 T cell
‘effectors’ on activation, albeit with an altered cytokine
balance, indicating that simple anergy is unlikely to be
the major modification involved.
Our data not only show that the unimodal distribution
contains functionally distinct subsets but that they differ
phenotypically as well. The NCD4lo cells have lower CD2
and MHCI levels, but higher CD5 and CD54 levels. They
are smaller, too, which may indicate some metabolic
downmodulation, although mitochondrial mass and
transmembrane potential are not notably altered in
them, suggesting that mitochondrially mediated cell
size determining factors may not be causal [46,47].
Non-mitochondrial possibilities, such as some potassium
channels that are reported to regulate homeostatic volume
in T cells, would need to be examined [48].
Notably, none of the functional and phenotypic differ-
ences between peripheral NCD4lo and NCD4hi T cells
are visible in thymic CD4SP cell subsets, suggesting
that the differences arise peripherally rather than being
programmed during thymic development. There are
interesting implications of the observation that even
the mature CD24- thymic CD4SP cells do not show
functional distinctions between their CD4lo and CD4hi
sub-populations. This indicates that, in thymic CD4SP
cells, variation in CD4 levels is indeed likely to be merely
stochastic and without functional consequences, as
would be expected if the normal distribution of CD4
levels in a cell population was due to biological noise
and not any functional heterogeneity. These findings
lend interpretative weight to our data with peripheral
NCD4 cells which do show that their CD4 levels correl-
ate with functional heterogeneity and time of peripheral
residence.It may be noted that any more direct functional com-
parisons between CD4SP thymocytes and peripheral
NCD4hi cells are difficult to make, since it is quite likely
that NCD4 reactivity is low in mature thymocytes for
reasons unrelated to cellular age, because recent thymic
emigrants in the periphery are poorly responsive and
take some time to reach peak reactivity [49,50].
One obvious distinction between lymphocyte subpop-
ulations can be envisaged based on clonal repertoire
diversity. However, relatively monoclonal TCR-transgenic
NCD4 cells also show similar differences. Thus, clonal
repertoire diversity is not an absolute prerequisite for
these differences.
CD5 levels on T cells have been linked to adaptation
and fine-tuning of T cell responsiveness [12,51], possibly
via tonic signaling through the restricting MHC element
which has been shown to be required for naïve T cell
survival, maintenance and homeostatic proliferation
in lymphopenic environments [52]. The correlation be-
tween CD5 levels on naive T cells and their responsive-
ness is somewhat controversial. Recently, higher CD5
levels have been correlated with better responsiveness
of NCD4 [1]. On the other hand, CD5 has been shown
to be a negative regulator of TCR-mediated activation
[53,54]. There are also other reports, consistent with
our findings, that tonic spMHC contact for both CD4
and CD8 T cells leads to both upregulation of CD5
levels and to induction of hyporeactivity [12,13]. The
differences in the correlation of CD5 levels on T cells
with higher or lower reactivity may be related to the
origin of the differences in CD5 levels; thus, it is
possible that between naive T cells that have received
tonic signals for comparable durations, higher CD5
levels may identify better-responding T cells as reported
[1]. However, in some situations, CD5 levels may pre-
dominantly reflect the duration of tonic signaling as
noted in previous literature [12,13] and in our data here,
and in that context, CD5 levels may be inversely corre-
lated with reactivity.
Notwithstanding these issues, it is currently plausible
to hypothesize that NCD4lo cells, which have higher
levels of CD5, may have received much more tonic
signal, possibly simply by having spent more time in
the periphery. Consistent with this possibility, when
NCD4hi cells are purified and transferred in vivo, their
CD4 levels slowly go down. This does not happen to
NCD4lo cells, possibly indicating that they have already
gone as low as possible in their CD4 levels. Further,
such parked cells steadily become hyporesponsive over
time, again implicating time of peripheral residence as
a regulatory influence. Thus, within a unimodal popu-
lation of NCD4 cells, it is likely that there are multiple
cohorts of cells with varying peripheral residence times
and, as a result, varying functionality.
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ation over residence time in vivo is MHC-mediated
tonic signaling which, while it is necessary for the survival
of naive T cells, has also been reported to be responsible
for attenuation of the response potential of these cells,
possibly through the negative regulatory function of
CD5 [12,13]. Indeed, parking NCD4 T cells in a MHCII-
deficient environment with an acute lack of tonic signaling,
for even a short three-day period of parking, reveals
MHCII-dependent differences in CD4 levels, CD5 levels
and in responsiveness. However, cell size does not
change over this time window, indicating that it is not
necessary for the hyporesponsiveness.
We observe that ROS levels go up in NCD4 cells as
time of peripheral residence increases, whether in the
severe situation of parking in MHCII-deficient mice, or
in the more physiological situation of parking in WT
lymphoreplete mice. In T cells, the mammalian Ste20-
like protein kinase Mst-1 is known to regulate SOD-2
and catalase levels [55], and Mst-1-deficient T cells, in
addition to showing lower levels of SOD2 and catalase,
have higher ROS levels and are sensitive to apoptosis.
The synthetic mimetic of catalase and SOD used here,
Euk134, has been used as an anti-oxidant in vivo for a
variety of outcomes ranging from prevention of heart
failure post-hypertension [41] to provision of pain relief
[56] in situations where ROS accumulation has been
implicated in the pathology.
In NCD4 cells, ROS does contribute to the functional
phenotype, since ROS scavenging significantly (though
not completely) protects NCD4 cells from prolonged
six-week parking-induced hyporesponsiveness. However,
this ROS-mediated contribution to hyporesponsiveness
requires fairly prolonged ROS exposure since 15-day anti-
oxidant treatment does not improve reactivity. Thus, while
ROS does make a contribution at late stages, it is clearly
not the major factor imposing hyporeactivity on NCD4
cells upon prolonged peripheral residence.
If tonic signaling eventually leads to hyporesponsiveness,
indications of such a change may be detectable as altered
baseline signaling activity [57,58]. In keeping with this,
baseline p-Erk levels are lower in NCD4lo T cells. Since
Erk phosphorylation has been reported to be controlled by
DUSP6 in human T cells, where DUSP6 is regulated by
the miR-181a, it was plausible to examine the miR-181a-
DUSP axis for a role in the functional differences between
NCD4lo and NCD4hi cells. Indeed, miR-181a levels are
lower in NCD4lo cells, and a DUSP inhibitor rescues both
the poor responsiveness and the Th2-skewing of these
cells. Thus, the miR-181a-DUSP axis is at least one mech-
anism contributing to the alteration of functionality over
peripheral residence time in NCD4 cells.
It is noteworthy that NCD4 T cells from aged animals
also show hyporesponsiveness similar to that of NCD4locells from young mice that we observed. As thymic out-
put decreases with age, naïve T cells in the periphery
appear to be longer-lived [16-18,31], and the average
peripheral residence time of naïve T cells is greater in
aged than in young individuals [32,33]. As would be
expected from this, the functional and phenotypic
characteristics related to peripheral residence time that
our data identified, low CD4 levels, small cell size, poor
responses and Th2-skewing, were more prominent in
NCD4 T cells from aged mice. While the CD4 T cell
defect in aged animals is likely to be multi-factorial in
origin [59,60], our data indicate that increased average
peripheral residence time of the cells is likely to be one
contributory factor.
Finally, our data also show that another molecular
component regulating the hyporesponsiveness shared
by both ANCD4 and NCD4lo cells is the Erk-DUSP6-
miR-181a axis. While TCR-mediated activation of T cells
from older humans and mice show many early-stage
defects in synapse formation and in phosphorylation-
mediated activation of critical kinases [52,61,62], recent
data suggest that increased DUSP6 activity in naïve
CD4 T cells from older humans may be important
in reducing their ability to respond to TCR-mediated
stimulation [8]. Our data show that miR-181a levels are
lower in both ANCD4 cells and in NCD4lo cells, and
the DUSP inhibitor enhances proliferative responses of
both ANCD4 and NCD4lo cells. It is interesting to note
that, although YNCD4 cells would consist of NCD4hi,
NCD4lo and NCD4-intermediate cells, the DUSP inhibitor
does not show any significant improvement in proliferative
responses of bulk YNCD4 cells. It is plausible that the
contribution of NCD4lo cells in the bulk YNCD4 cells
may not be statistically apparent in the assays we have
used. Our findings extend the reported findings from
the human system to the mouse system, and establish
further concordance between ANCD4 and NCD4lo T cells
and confirm that this axis may indeed be specifically
affected during cellular aging. While linkages between
increased ROS levels and phosphatase activity of DUSP6
have been shown in non-T cells [63,64] whether such a
link exists in aging NCD4 T cells is not yet clear.
Conclusions
Our data show that, despite unimodal distribution of
CD4 on NCD4 cells, there are subsets of NCD4 cells
that differ in their peripheral residence time. During
this period, they are in receipt of MHCII-mediated sig-
nals and show alteration of phenotype and functionality
via ROS and DUSP activity. Our findings thus indicate
the feasibility of potential pharmacological interventions
via small molecules serving either as anti-oxidants or as
DUSP inhibitors, directed specifically at CD4 T cells
during vaccination of older people.
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Mice
All mice were obtained from Jackson Laboratories (Bar
Harbor, ME, USA) and bred at the Small Animal Facility
of the National Institute of Immunology, New Delhi, India.
The following mouse strains were used: C57BL/6 (B6; H-
2b, CD45.2, CD90.2), B6.SJL (H-2b, CD45.1), MHCII−/−
(H-2b), Balb.c (H-2d) and TCR-transgenic (Tg) OT-II
(H-2b), and DO11.10 (H-2d). At the initiation of experi-
ments all mice were six- to eight-weeks of age, except
aged B6 mice which were >18 months of age. OT-II
mice were crossed with B6.SJL mice, F1 progeny were
screened for the presence of the transgene to identify
TCR-Tg mice which were further used, as appropriate, for
each experiment. Cells from DO11.10, OT-II or OT-IIxB6.
SJL mice were adoptively transferred i.v. to appropriate
recipients.
Adoptive transfer experiments
Mouse spleen cells (containing 5 × 106 OT-II or DO11.10
cells per mouse) or further sorted populations, as men-
tioned wherever appropriate, suspended in normal saline,
were transferred into anesthetized recipient mice i.v. Cells
were parked in the recipient mice for various time periods
as mentioned. For transfer to B6 and MHCII−/− mice,
NCD4 cells were sorted from OT-IIxB6.SJL mice and 5 ×
106 cells were transferred i.v. Three or ten days post-
transfer recipient mice were euthanized and transferred
NCD4 cells were distinguished from endogenous NCD4
cells using CD45.1 as a marker. Euk134 was given intra-
peritoneally (i.p.) (25 mg/kg) on alternate days for two or
five weeks [41] with dimethysulfoxide in normal saline as
control.
Reagents
For all cell culture experiments, Roswell Park Memorial
Institute (RPMI)-1640 (Biological Industries, Beit Haemek,
Israel) with 10% heat inactivated fetal bovine serum
(Euroclone, Pero, Italy), 2 mM glutamine, 55 nM β-
mercaptoethanol (Sigma-Aldrich, Bengaluru, India), an-
tibiotics and antimycotics (Sigma-Aldrich) was used.
Mouse CD2, CD4, CD5, CD8, CD24, CD25, CD44, CD54,
CD62L, CD69, Qa2, KJ1.26, TCRβ, MHC-I, Zap-70,
pZap-70, Lck, p-Lck, Erk, p-Erk and human CD4,
CD45RA, CD25 were detected with specific fluorochrome-
coupled anti-mouse or anti-human Abs (BD Biosciences,
New Jersey, USA; eBioscience, San Diego, CA, USA;
BioLegend, San Diego, CA, USA; Cell Signaling Technology,
Danvers, MA, USA; Millipore, Merck, Darmstadt,
Germany). Fluo-3 AM and Fura-Red AM (Life Technolo-
gies, Carlsbad, CA, USA) were used to study calcium flux.
For scoring mitochondrial mass and potential, Mitotracker
Green (MG) and Mitotracker Red (MR) (Molecular
Probes, Carlsbad, CA, USA) were used respectively. Forestimation of ROS, cells were incubated with the cell-
permeant dye 2-7-dichlorofluorescin diacetate (DCFDA,
Molecular Probes). For anti-oxidant treatment, Euk-134
(Cayman Chemical, Ann Arbor, Michigan, USA) was
dissolved in dimethysulfoxide (Sigma-Aldrich) and di-
luted to the required concentration in normal saline.
For inhibiting DUSP in T cells (E)-2-benzylidene-3-
(cyclohexylamino)-2, 3-dihydro-1H-inden-1-one (BCI,
Sigma Aldrich) was used.
Isolation and purification of cells
Following euthanasia, single cell suspensions of mouse
spleen cells were prepared, subjected to red cell lysis,
and stained with anti-mouse CD4, CD25, CD44 and
CD62L Abs and electronically sorted (FACSAria III, BD)
for naïve CD4 T cells (CD4 + CD25-CD44-CD62L+). For
sorting NCD4lo and NCD4hi cells, further gating was
done for the approximately 10% NCD4lo and approxi-
mately 10% NCD4hi populations in the NCD4 gated
population. For sorting CD4lo and CD4hi mature single
positive thymic cells, thymic single cell suspensions were
made from young B6 mice, stained with CD4, CD8,
CD24 and Qa2. CD4 + CD8-CD24-Qa2+ cells identified
as mature CD4 cells were further gated for CD4lo and
CD4hi and sorted as for peripheral cells.
Blood from healthy, young, consenting adults between
the ages of 22 and 35 years (n = 10) with equal represen-
tation of men and women was collected and PBMCs
separated from heparinized blood by density gradient
centrifugation using Ficoll-PaqueTM PREMIUM (GE
Healthcare Biosciences AB, Little Chalfont, UK). For
sorting human NCD4hi and NCD4lo cells, CD4 + CD25-
CD45RA+ low forward scatter cells were gated for
NCD4lo and NCD4hi as described for mouse cells and
sorted. After sorting, individual fractions were >98%
pure in all cases.
Staining of cells for phenotypic analysis by flowcytometry
Splenic cells from a six- to eight-week old B6 or B6.SJL
mouse spleen were identified as NCD4 cells (CD4 +
CD44-CD62L + CD25-), highest and lowest deciles were
identified on CD4 histogram as NCD4hi and NCD4lo
and analyses of their MFI values for CD2, CD4, CD5,
CD54, MHC-I, TCRβ, forward scatter, p-Erk, pZap-70,
MG and MR were done as paired samples. Splenic cells
from 18-month old B6 mice were mixed in equal num-
bers with splenic cells from six- to eight-week old B6.
SJL mice and stained for CD45.1, CD45.2, CD4, CD44,
CD62L and CD25 to identify naïve CD4 cells. MFI
values on these cells for various markers were com-
pared as paired samples in a given assay for statistical
analysis.
For evaluation of proximal signaling, splenic cells
(approximately 1 × 107) were loaded with 0.5 μM of
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followed by surface staining for identifying NCD4 cells
at 4°C. Stained cells were brought back to 37°C and base-
line readings obtained. T cells were activated with anti-
CD3 + anti-CD28 (10 + 3 μg/ml, respectively), followed by
ionomycin (Sigma). For pZap-70 and pLck a similar stain-
ing and activation protocol was followed without using
dyes mentioned for calcium measurements.
For evaluating the stability of NCD4hi and NCD4lo
cells in vivo, cells were sorted from six- to eight-week
old B6 mice. NCD4hi cells were labelled with CFSE
whereas NCD4lo cells were labelled with CellTrace Violet.
A total of 2 × 106 NCD4hi cells were mixed with 2 × 106
NCD4lo cells and transferred to age-matched B6 recipients.
An aliquot of a mixture of cells was cryopreserved in 10%
dimethyl sulfoxide (DMSO) containing FCS at −70°C.
Mice were euthanized four or seven days later and their
splenic cells were similarly cryopreserved and thawed
along with cells cryopreserved on d0. These cells were
stained for CD4, CD44 and CD62L and transferred cells
in donor splenocytes were identified based on the dyes
used for staining before transfer. Relative CD4 expression
levels on these populations on the day of transfer were
compared with those on day 4 post-transfer. Spleens from
recipient WTand MHCII−/− mice were stained in parallel
to obtain MFI values for CD4, CD5 and DCFDA on trans-
ferred cells and treated as paired samples for statistical
analysis.
For long-term parking experiments involving parking
period up to eight weeks, OT-II (CD45.2) cells were
transferred to B6.SJL mice and parked for differing pe-
riods as indicated. Recipient mice were euthanized on
the same day and MFIs of CD4 and DCFDA on OT-II
cells with different parking periods were compared as
paired samples for statistical analysis. DO11.10 cells
transferred in Balb.c mice were identified as CD4 +
KJ1.26+ cells. Recipient mice with six months or two
weeks parking times were euthanized on the same day
and CD4 levels compared.
For phenotypic analysis of human PBMCs, NCD4 cells
were identified as CD4 + CD45RA + CD25-. NCD4hi
and NCD4lo subsets were further identified as described
for mouse cells. PBMCs were stained for MG and MR.
MFIs for CD4, forward scatter, MG and MR were com-
pared on NCD4hi and NCD4lo cells as paired samples
for statistical analysis.
For all the stainings, protocols recommended by the
manufacturers were used.
In vitro assays
All sorted cells were incubated in FCS-containing
medium at 37°C for two to three hours before setting up
functional assays. For naïve T cell stimulation, plates
were coated with a mixture of functional grade anti-mouse CD3 and anti-mouse CD28 Abs (e-Biosciences)
or purified anti-human CD3 and anti-human CD28 Abs
(BD Biosciences). Optimum concentrations of mAbs were
determined prior to use. Human CD4 cell cultures were
supplemented with 30 U/ml recombinant IL-2 (Roche,
Basel, Switzerland). For OT-II cell stimulation, titrating
doses of OVA-II peptide (a.a. 323–339, Peptron Inc.,
Daejeon, Republic of Korea) were used along with BMDCs
as APCs obtained as described earlier [65]. Proliferation was
measured by 3H-thymidine (Perkin Elmer, Waltham, MA,
USA) incorporation in the last 8 to 16 hours of a 60 to
72 hour assay. CD69 upregulation was measured by flow cy-
tometry 16 to 20 hours post-activation. Proliferation of poly-
clonal NCD4hi and NCD4lo cells by anti-CD3+ anti-CD28
mAbs was also measured by CFSE dilution, where at the
end of 60 to 72 hours dead cells staining positive with Sytox
Red were gated out before comparing proliferation curves.
For polyclonal naïve T cell differentiation, purified
mouse cells were activated as above for 72 hours, rested
in IL-2 (5 U/ml) for 24 hours and restimulated on
plates coated with anti-CD3 + anti-CD28 for 24 hours
to collect supernatants. Amounts of secreted IL-2,
interferon-gamma (IFNγ), IL-4 and IL-13 were ana-
lyzed using commercial reagents (eBioscience) and fol-
lowing recommended protocols. Concentrations were
calculated from absorbance values using recombinant
standards.
In all flow cytometric measurements, dead cells were
identified by Sytox red (Molecular Probes) or Annexin-V
(BD Biosciences) staining and excluded. In death assays
in vitro, dead cells in cultures of sorted cell populations
were identified by microscopy as trypan blue-stained
cells. For inhibition of DUSP6, cells were treated with
BCI (1 nM) for one hour at 37°C and washed prior to
activation. The optimum, non-toxic concentration of
BCI was determined for mouse cells prior to use.
Real time PCR for miR-181a and miR142
RNA was extracted from approximately two million puri-
fied NCD4hi, NCD4lo, ANCD4 and YNCD4 cells using
Trizol (Invitrogen, Carlsbad, CA, USA) following the man-
ufacturer’s instructions. For cDNA synthesis 1 μg RNA was
used for each sample using the MiScript HiSpec buffer
from the miScript-II RT kit to get mature miRNA (Qiagen,
Limburg, Netherlands). The miRNA real time PCR assays
were performed for mature miRNAs using commercial kits
(miScript Primer Assays for Mm_miR-181a_2, targeting the
sequence AACAUUCAACGCUGUCGGUGAGU, along
with miScript SYBR Green PCR kit, both from Qiagen).
Recommended protocols were used to obtain Ct values.
ΔΔCt values were calculated using miRNA-142 as a nor-
malizing control (miScript Primer Assays for Mm_miR-
142-5p_1 targeting CAUAAAGUAGAAAGCACUACU,
from Qiagen) based on a published report [8].
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Flow cytometric data were analyzed using FlowJo (Treestar,
San Carlos, CA, USA). Microsoft Excel was used for linear
histogram plotting of flow cytometric data. For statistical
analysis on paired samples, either Student’s paired ‘t’ test
or non-parametric tests, such as the Wilcoxon rank sum
test, was used. Student’s ‘t’ test or the Mann–Whitney u
test were used for other samples. Values of P <0.05 were
considered statistically significant.
Study approval
All mice were maintained and used according to the guide-
lines of, and with the approval of, the Institutional Animal
Ethics Committee of National Institute of Immunology.
Collection of human healthy volunteer blood was done by
venipuncture after obtaining written informed consent,
with due prior approval of the Institutional Human Ethics
Committee of National Institute of Immunology. All the
experimental work was done at the National Institute
of Immunology from where ethical permissions were
obtained.
Additional files
Additional file 1: Figure S1. Additional figure providing NCD4lo and
NCD4hi functional features.
Additional file 2: Figure S2. Additional figure providing NCD4lo and
NCD4hi phenotypic and functional features.
Additional file 3: Figure S3. Additional figure providing data on NCD4
levels in an independent TCR-Tg mouse strain and shorter treatment of
Euk-134 in vivo.
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